4-121902868-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001130698.2(TRPC3):c.2447G>A(p.Gly816Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000484 in 1,610,224 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001130698.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPC3 | NM_001130698.2 | c.2447G>A | p.Gly816Asp | missense_variant | 9/12 | ENST00000379645.8 | NP_001124170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPC3 | ENST00000379645.8 | c.2447G>A | p.Gly816Asp | missense_variant | 9/12 | 1 | NM_001130698.2 | ENSP00000368966.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 247964Hom.: 0 AF XY: 0.000164 AC XY: 22AN XY: 133940
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1458084Hom.: 1 Cov.: 29 AF XY: 0.0000703 AC XY: 51AN XY: 725058
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.2447G>A (p.G816D) alteration is located in exon 9 (coding exon 9) of the TRPC3 gene. This alteration results from a G to A substitution at nucleotide position 2447, causing the glycine (G) at amino acid position 816 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at